Clinical Trials Directory

Trials / Completed

CompletedNCT05424146

Efficacy of Evidence-Based PTSD Treatment Via Prebiotic Supplementation

Enhancing the Efficacy of Evidence-Based PTSD Treatment Via Microbiota-Directed Prebiotic Supplementation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Rush University Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder, which results from exposure to traumatic events. Veterans are more than twice as likely to suffer from PTSD compared to civilians. Current interventions for the treatment of PTSD are evidence-based psychotherapies, such as Cognitive Processing Therapy (CPT). Therefore, we plan to compare Cognitive Processing Therapy (CPT) with and without a novel prebiotic bar designed to beneficially modulate the microbiota to determine the utility of this combined approach to positively impact PTSD symptoms. We will conduct a 12-week randomized, double-blind, placebo-controlled, cross-sectional trial in veterans with PTSD. Participants will be randomized to receive CPT + prebiotic or CPT + placebo. They will be provided a supply of prebiotic or non prebiotic bars for 12 weeks. At three different time points, participants will complete questionnaires and complete questionnaires and produce a stool sample ( weeks 1,2, and 12). All participants will be recruited from the two-week in-person Intensive Outpatient Program (IOP) at the Rush Road Home Program, where they will be receiving CPT.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPrebiotic Bar +CPTParticipants will be instructed to consume 1 prebiotic bar once daily for 1 week CPT. Starting week 2 they will be asked to consume 1 prebiotic bar twice daily.
BEHAVIORALNon-Prebiotic Bar +CPTParticipants will be instructed to consume 1 non-prebiotic bar once daily for 1 week while receiving CPT. Starting week 2 they will be asked to consume 1 non-prebiotic bar twice daily.

Timeline

Start date
2022-06-06
Primary completion
2023-07-05
Completion
2023-07-05
First posted
2022-06-21
Last updated
2024-04-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05424146. Inclusion in this directory is not an endorsement.